AlphAIalphai — Financial news for AI agents
prnewswire.comAUG 62 min read$RERE

ATRenew to Report Second Quarter 2026 Financial Results on August 20, 2026

ATRenew Inc. (NYSE: RERE) said it will release unaudited second-quarter 2026 financial results before the U.S. market opens on Aug. 20, 2026. The company plans an earnings call at 8:00 a.m. ET that day and will post a webcast and replay on its investor relations site.

Original reporting
prnewswire.com
Published Aug 6, 2026, 11:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 11:56 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefFinancial news
Primary signal
$RERE
Neutral
medium confidence
Mentioned
$RERE
Relevance
5/10
alphai data visualization · based on prnewswire.com
Decision brief

The 30-second read

$RERENeutralMed
01

Why it matters

The primary tradable element is event timing for earnings volatility and positioning. No new fundamentals, guidance, or surprises are provided in this release.

02

Market read

Event-driven traders can plan around the Aug. 20 pre-market earnings release and the 8:00 a.m. ET call.

03

What to watch

Traders should still watch for any subsequent pre-announcement, guidance updates, or unusual options-implied moves into the Aug. 20 event, which are not covered here.

Relevance 5/10Novelty 5/10Timing: ahead of Aug. 20, 2026 pre-market Q2 earnings release

Background

ATRenew is a China-focused recycling and trade-in platform. The company scheduled its Q2 2026 unaudited results release and an earnings call.

Company-level read

Ticker impact

$RERENeutralMedium confidence
Context

ATRenew announced it will release unaudited Q2 2026 results before the U.S. open on Aug. 20, 2026, with a call at 8:00 a.m. ET.

Expected impact

Likely elevated volatility and positioning ahead of the Aug. 20 pre-market earnings release; direction depends on the eventual Q2 print.

Evidence & confidence

The article discloses no Q2 numbers or guidance, only the scheduled release date/time and call logistics, which is still actionable for event-driven trading.

Market effects

Sector

Limited sector read-through because the release contains no operational or guidance details.

Regional

Minimal, as the disclosure is company-specific and not a China macro or regulatory event.

Global

Low, since it is a single-company earnings scheduling update with no new financial datapoints.

Counterpoint

What could challenge this read

Because the release is only a scheduling notice with no numbers, it may not change expectations materially versus what the market already anticipates.

Key entities

  • company
    ATRenew Inc.

    Announced timing for unaudited Q2 2026 financial results and the associated earnings conference call.

  • security
    NYSE: RERE

    ATRenew’s listed equity referenced in the announcement.

Read at source← All news

Related articles

AUG 27
$REREMedAI 8/10

ATRenew (RERE): Secondhand Tech Giant Quietly Posting Record Profits

ATRenew (RERE) reported Q2 revenue of RMB 6.6B (+32.4% YoY) and net income of RMB 129.1M (+78.6% YoY). The company's 1P model drove growth, with gross margin rising to 15.7%. However, net service revenue fell 4.2% and gold recycling revenue dropped 35%. ATRenew expects Q3 revenue of RMB 6.3B-6.4B, a slower growth rate.

yahoo.com5 min
AUG 21
$REREMedAI 8/10

ATRenew Q2 Earnings Call Highlights

ATRenew reported Q2 merchandise costs rose 31.9% to CNY 5.22B, with 1P gross profit margin improving to 15.7%. The company expanded its door-to-door team to 3,000 and operated 2,117 stores. It repurchased 1M ADS for $4.2M and extended a $50M repurchase program. Net service revenue declined 4.2% due to merchant subsidies. PJT Marketplace had 20.27M merchants, with 84.4% third-party warehousing penetration. ATRenew forecasts Q3 revenue of CNY 6.34B-CNY 6.44B, up 23.1%-25.1% YoY.

yahoo.com2 min
AUG 21
$REREMed

ATRenew (RERE) Q2 2026 Earnings Call Transcript

ATRenew (RERE) reported Q2 2026 revenues of RMB 6.61B, up 32.4% YoY. Product revenue grew 35.9% YoY, while non-GAAP operating profit rose 70.1% YoY to RMB 206.3M. The company highlighted growth in 1P business, strong recycling demand, and expansion in pre-owned device exports.

yahoo.com3 min
AUG 20
$REREHigh

ATRenew Inc. (RERE): Financial results for Q2 2026

ATRenew Inc. (RERE) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 ATRenew Inc. Reports Unaudited Second Quarter 2026 Financial Results SHANGHAI, Aug. 20, 2026 /PRNewswire/ -- ATRenew Inc. ("ATRenew" or the "Company") (NYSE: RERE), a pioneer in technology-driven recycling and trade-in solutions for consumer products in China, today

SEC EDGAR 6-K2 min
AUG 20
$REREMed

ATRenew Inc. Reports Unaudited Second Quarter 2026 Financial Results

ATRenew Inc. (NYSE: RERE) reported Q2 2026 earnings with total net revenues up 32.4% YoY to RMB6,609.3 million. Operating income rose 95.7% to RMB178.3 million, while net income increased 78.6% to RMB129.1 million. The company transacted 11.6 million consumer products. ATRenew expects Q3 2026 revenues between RMB6,340.0 million and RMB6,440.0 million, up 23.1%-25.1% YoY. The board authorized a US$50 million share repurchase program, with US$35.2 million remaining as of Q2 2026.

prnewswire.com2 min
SEP 8
$BNTXMed

BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy?

BioNTech (NASDAQ:BNTX) halted a mid-stage trial of its mRNA cancer vaccine, autogene cevumeran, due to an overall survival imbalance. The decision raises concerns about its mRNA strategy in colorectal cancer and other 'cold' tumors. BioNTech plans to continue other trials, including one for pancreatic cancer and BNT113 for head and neck cancer. The company also focuses on diversifying its oncology pipeline. According to Reuters, the news caused a 7.5% drop in BioNTech's US-listed shares.

yahoo.com3 min